vs
Indivior Pharmaceuticals, Inc.（INDV）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Indivior Pharmaceuticals, Inc.的季度营收约是Revolve Group, Inc.的1.1倍（$357.0M vs $324.4M），Indivior Pharmaceuticals, Inc.净利率更高（28.9% vs 5.7%，领先23.1%），Revolve Group, Inc.自由现金流更多（$-13.3M vs $-245.0M）
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
INDV vs RVLV — 直观对比
营收规模更大
INDV
是对方的1.1倍
$324.4M
净利率更高
INDV
高出23.1%
5.7%
自由现金流更多
RVLV
多$231.7M
$-245.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $357.0M | $324.4M |
| 净利润 | $103.0M | $18.6M |
| 毛利率 | 82.1% | 53.3% |
| 营业利润率 | 22.7% | 6.3% |
| 净利率 | 28.9% | 5.7% |
| 营收同比 | — | 10.4% |
| 净利润同比 | 390.5% | 50.4% |
| 每股收益（稀释后） | $0.79 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INDVRVLV
| Q4 25 | $357.0M | $324.4M | ||
| Q3 25 | $314.0M | $295.6M | ||
| Q2 25 | $302.0M | $309.0M | ||
| Q1 25 | $266.0M | $296.7M | ||
| Q4 24 | — | $293.7M | ||
| Q3 24 | $307.0M | $283.1M | ||
| Q2 24 | $299.0M | $282.5M | ||
| Q1 24 | — | $270.6M |
净利润INDVRVLV
| Q4 25 | $103.0M | $18.6M | ||
| Q3 25 | $42.0M | $21.2M | ||
| Q2 25 | $18.0M | $10.2M | ||
| Q1 25 | $47.0M | $11.8M | ||
| Q4 24 | — | $12.3M | ||
| Q3 24 | $22.0M | $11.0M | ||
| Q2 24 | $-97.0M | $15.4M | ||
| Q1 24 | — | $10.9M |
毛利率INDVRVLV
| Q4 25 | 82.1% | 53.3% | ||
| Q3 25 | 73.2% | 54.6% | ||
| Q2 25 | 82.8% | 54.1% | ||
| Q1 25 | 83.1% | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | 78.5% | 51.2% | ||
| Q2 24 | 73.6% | 54.0% | ||
| Q1 24 | — | 52.3% |
营业利润率INDVRVLV
| Q4 25 | 22.7% | 6.3% | ||
| Q3 25 | 13.7% | 7.1% | ||
| Q2 25 | 23.8% | 5.8% | ||
| Q1 25 | 24.8% | 5.0% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | 11.4% | 5.0% | ||
| Q2 24 | -39.5% | 5.8% | ||
| Q1 24 | — | 3.4% |
净利率INDVRVLV
| Q4 25 | 28.9% | 5.7% | ||
| Q3 25 | 13.4% | 7.2% | ||
| Q2 25 | 6.0% | 3.3% | ||
| Q1 25 | 17.7% | 4.0% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | 7.2% | 3.9% | ||
| Q2 24 | -32.4% | 5.4% | ||
| Q1 24 | — | 4.0% |
每股收益（稀释后）INDVRVLV
| Q4 25 | $0.79 | $0.27 | ||
| Q3 25 | $0.33 | $0.29 | ||
| Q2 25 | $0.14 | $0.14 | ||
| Q1 25 | $0.38 | $0.16 | ||
| Q4 24 | — | $0.18 | ||
| Q3 24 | $0.16 | $0.15 | ||
| Q2 24 | $-0.72 | $0.21 | ||
| Q1 24 | — | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.0M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-98.0M | $512.5M |
| 总资产 | $1.2B | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INDVRVLV
| Q4 25 | $195.0M | $292.3M | ||
| Q3 25 | $445.0M | $315.4M | ||
| Q2 25 | $510.0M | $310.7M | ||
| Q1 25 | $373.0M | $300.8M | ||
| Q4 24 | — | $256.6M | ||
| Q3 24 | — | $252.8M | ||
| Q2 24 | — | $244.7M | ||
| Q1 24 | — | $273.4M |
股东权益INDVRVLV
| Q4 25 | $-98.0M | $512.5M | ||
| Q3 25 | $-207.0M | $490.2M | ||
| Q2 25 | $-257.0M | $468.6M | ||
| Q1 25 | $-285.0M | $453.4M | ||
| Q4 24 | — | $437.8M | ||
| Q3 24 | $-310.0M | $420.8M | ||
| Q2 24 | $-281.0M | $405.8M | ||
| Q1 24 | — | $389.9M |
总资产INDVRVLV
| Q4 25 | $1.2B | $765.0M | ||
| Q3 25 | $1.4B | $751.3M | ||
| Q2 25 | $1.5B | $722.9M | ||
| Q1 25 | $1.4B | $713.9M | ||
| Q4 24 | — | $665.5M | ||
| Q3 24 | — | $670.9M | ||
| Q2 24 | — | $657.8M | ||
| Q1 24 | — | $650.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-221.0M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $-245.0M | $-13.3M |
| 自由现金流率自由现金流/营收 | -68.6% | -4.1% |
| 资本支出强度资本支出/营收 | 6.7% | 1.0% |
| 现金转化率经营现金流/净利润 | -2.15× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $-93.0M | $48.0M |
8季度趋势，按日历期对齐
经营现金流INDVRVLV
| Q4 25 | $-221.0M | $-10.2M | ||
| Q3 25 | $-39.0M | $11.8M | ||
| Q2 25 | $158.0M | $12.6M | ||
| Q1 25 | $75.0M | $45.1M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | $2.0M | $9.1M | ||
| Q2 24 | $88.0M | $-24.7M | ||
| Q1 24 | — | $38.4M |
自由现金流INDVRVLV
| Q4 25 | $-245.0M | $-13.3M | ||
| Q3 25 | $-59.0M | $7.5M | ||
| Q2 25 | $141.0M | $10.4M | ||
| Q1 25 | $70.0M | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | $-5.0M | $8.0M | ||
| Q2 24 | $84.0M | $-25.7M | ||
| Q1 24 | — | $36.7M |
自由现金流率INDVRVLV
| Q4 25 | -68.6% | -4.1% | ||
| Q3 25 | -18.8% | 2.5% | ||
| Q2 25 | 46.7% | 3.4% | ||
| Q1 25 | 26.3% | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | -1.6% | 2.8% | ||
| Q2 24 | 28.1% | -9.1% | ||
| Q1 24 | — | 13.5% |
资本支出强度INDVRVLV
| Q4 25 | 6.7% | 1.0% | ||
| Q3 25 | 6.4% | 1.5% | ||
| Q2 25 | 5.6% | 0.7% | ||
| Q1 25 | 1.9% | 0.6% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | 2.3% | 0.4% | ||
| Q2 24 | 1.3% | 0.4% | ||
| Q1 24 | — | 0.6% |
现金转化率INDVRVLV
| Q4 25 | -2.15× | -0.55× | ||
| Q3 25 | -0.93× | 0.56× | ||
| Q2 25 | 8.78× | 1.24× | ||
| Q1 25 | 1.60× | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | 0.09× | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | — | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
